Business Description
QSAM Biosciences Inc
NAICS : 541714
SIC : 2833
ISIN : US74737G1094
Description
QSAM Biosciences Inc is a clinical-stage novel radiopharmaceutical company. The company is developing treatments for bone cancer and related diseases.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 173.25 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 66.5 | |||||
| 3-Year EPS without NRI Growth Rate | 65.3 | |||||
| 3-Year FCF Growth Rate | 44.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.51 | |||||
| 9-Day RSI | 65.11 | |||||
| 14-Day RSI | 66.58 | |||||
| 6-1 Month Momentum % | 59.57 | |||||
| 12-1 Month Momentum % | 22.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.65 | |||||
| Quick Ratio | 1.65 | |||||
| Cash Ratio | 1.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -94.9 | |||||
| Shareholder Yield % | -1.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -495.49 | |||||
| ROIC % | -4098.75 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 160 | |||||
| Price-to-Tangible-Book | 160 | |||||
| EV-to-EBIT | -8.78 | |||||
| EV-to-EBITDA | -8.78 | |||||
| EV-to-FCF | -12.26 | |||||
| Price-to-Net-Current-Asset-Value | 160 | |||||
| Price-to-Net-Cash | 80 | |||||
| Earnings Yield (Greenblatt) % | -11.39 | |||||
| FCF Yield % | -8.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:QSAM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
QSAM Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.78 | ||
| Beta | 0.64 | ||
| Volatility % | 76.69 | ||
| 14-Day RSI | 66.58 | ||
| 14-Day ATR ($) | 0.202356 | ||
| 20-Day SMA ($) | 7.621 | ||
| 12-1 Month Momentum % | 22.95 | ||
| 52-Week Range ($) | 4 - 8.39 | ||
| Shares Outstanding (Mil) | 4.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
QSAM Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
QSAM Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
QSAM Biosciences Inc Frequently Asked Questions
What is QSAM Biosciences Inc(QSAM)'s stock price today?
The current price of QSAM is $8.00. The 52 week high of QSAM is $8.39 and 52 week low is $4.00.
When is next earnings date of QSAM Biosciences Inc(QSAM)?
The next earnings date of QSAM Biosciences Inc(QSAM) is .
Does QSAM Biosciences Inc(QSAM) pay dividends? If so, how much?
QSAM Biosciences Inc(QSAM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers